Moreover, miR-206 is a negative key regulator of oncogenic KRAS-induced NF-κB transcriptional activity, which leads to reduced proangiogenic and proinflammatory factors that further result in tumor growth and poor prognosis. The gene discussed is KRAS; the disease is neoplasm.